Kazia Therapeutics Ltd (NAS:KZIA)
$ 12 -0.32 (-2.6%) Market Cap: 186.60 Mil Enterprise Value: 140.51 Mil PE Ratio: 0 PB Ratio: 4.41 GF Score: 33/100

Kazia Therapeutics Ltd Annual Shareholders Meeting Transcript

Mar 25, 2026 / 10:00PM GMT
Release Date Price: $7.3 (+2.38%)
Bryce Carmine
Kazia Therapeutics Ltd - Non-Executive Independent Director

(audio in progress) Therapeutics. As the time is now 9:00 AM and a quorum is present, I formally declare the Annual General Meeting of Kazia Therapeutics Limited open.

As set out in the Notice of Meeting, the Annual General Meeting is being held as a fully virtual meeting.

We are joined today by our CEO, Dr. John Friend; along with my fellow Non-Executive Directors Steve Coffey, Ebru Davidson, and Robert Apple.

I welcome all attendees to the meeting.

Please note, only shareholders and proxy holders are able to ask questions and vote at the meeting. For shareholders and proxy holders who wish to ask a question, you can submit them at any time through the Q&A tab later in the meeting.

Before we move to the formal business of the meeting, I would like to share a personal note:

I have decided that I will be stepping back and retiring from the Board of Kazio Therapeutics, as of March 31, 2026. It has been a privilege to serve as Chairman and work alongside a talented and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot